SCHEMBL4927779

SCHEMBL4927779

Cc1cc(=O)oc2c1ccc1c2ccn1C(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.42
▸ CYP1A1 P04798 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ KDM4E B2RXH2 7/20 0.41
▸ GAA P10253 4/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ MAOB P27338 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ MCL1 Q07820 2/20 0.40
▸ MGAM O43451 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ SI P14410 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4919565 0.72 MAOA (0.39) MAOAKDM4EGAAHSD17B10KMT2A
SCHEMBL14113111 0.67 MAOA (0.48) MAOAKDM4EGAAHSD17B10KMT2A
SCHEMBL4928161 0.65 MAOA (0.47) MAOAKDM4EGAAHSD17B10KMT2A
SCHEMBL2114921 0.64 NOTUM (0.50) KDM4EGAAHSD17B10KMT2AHPGD
SCHEMBL4919783 0.62 CA12 (0.50) CYP1A2KDM4EGAAHSD17B10KMT2A
SCHEMBL11143079 0.61 LMNA (0.42) CYP1A2KDM4EGAAHSD17B10KMT2A
SCHEMBL2116947 0.61 NOTUM (0.44) CYP1A2KDM4EGAAKMT2ALMNA
SCHEMBL6331868 0.60 CYP1A2 (1.00) CYP1A1CYP1A2CYP1B1KDM4EGAA
SCHEMBL8835293 0.60 KDM4E (0.71) MAOACYP1A2KDM4EGAAHSD17B10
SCHEMBL20224102 0.60 NOTUM (0.43) CYP1A2KDM4EHSD17B10HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT MAOA 1/4885CYP1A1 30/4885CYP1A2 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback